SPTBN2: A Potential Drug Target and Biomarker (G6712)

Target Name: SPTBN2

NCBI ID: G6712

SPTBN2: A Potential Drug Target and Biomarker

Spectrin beta III sigma 2 (SPTBN2) is a protein that is expressed in various tissues of the body, including muscle, heart, and brain. It is a key component of the spectrin protein family, which plays a critical role in the structure and function of actin filaments. SPTBN2 has been shown to have various functions in various cellular processes, including the regulation of cell division, differentiation, and stress responses.

SPTBN2 has also been identified as a potential drug target in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these diseases, as well as its potential as a drug target, makes it an attractive target for research and development of new treatments.

The biology of SPTBN2 is well understood, and its functions have been extensively studied. SPTBN2 is a 21-kDa protein that consists of 155 amino acid residues. It has a molecular weight of 19,112 Da and a calculated pI of 6.4. SPTBN2 is predominantly expressed in muscle and heart, and is also found in various other tissues, including brain, liver, and kidney.

SPTBN2 is involved in the regulation of actin filament dynamics and stability, which are critical for the proper functioning of cells. It plays a key role in the regulation of cell division, as it is involved in the metaphors of mitosis and meiosis. SPTBN2 is also involved in the regulation of cell stress responses, as well as in the regulation of cytoskeletal organization.

SPTBN2 has also been shown to play a role in the regulation of cell migration and the formation of tissues. It has been shown to be involved in the regulation of the assembly and disassembly of actin filaments, as well as in the regulation of the organization of cytoskeletal components.

In addition to its functions in cellular processes, SPTBN2 has also been shown to play a role in the regulation of various cellular processes outside of the cell. It has been shown to be involved in the regulation of inflammation, as well as in the regulation of cellular signaling pathways.

SPTBN2 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its expression has been shown to be elevated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

SPTBN2 has also been shown to have a unique expression pattern in various tissues, which may be a potential target for specific therapies. For example, SPTBN2 has been shown to be expressed in muscle, heart, brain, and liver, but not in the lungs or the kidneys. This may suggest that specific therapies that target SPTBN2 in these tissues may be effective in treating certain diseases.

In conclusion, SPTBN2 is a protein that has various functions in cellular processes, including the regulation of actin filament dynamics and stability, the regulation of cell division, stress responses, and cell migration. Its functions make it an attractive target for research and development of new treatments for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique expression pattern in various tissues also makes it a potential biomarker for these diseases. Further research is needed to fully understand the role of SPTBN2 in these diseases and to develop effective therapies.

Protein Name: Spectrin Beta, Non-erythrocytic 2

Functions: Probably plays an important role in neuronal membrane skeleton

More Common Targets